Check out this month's People Pathways newsletter for your monthly round-up of employee engagement activities.

AMSBIO has added a new range of Vesicular Stomatitis Virus (VSV) to its suite of virus-based tools for cell engineering and the study of viral infection. Vesicular Stomatitis Virus is an enveloped, negative-stranded RNA virus with a simple structure. Its ability to infect a wide range of mammalian cell types has made it a valuable tool to study virus entry, replication, and assembly. A key advantage of the AMSBIO VSV model is that it undergoes only one round of replication. Consequently, it is safe to use and requires only a biosafety level 2 facility. VSV vectors offer a robust model of…

ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women's health, has announced the formation of a new subsidiary company, Cytolytix Limited, which has signed an IP license agreement with Kings College London to progress the preclinical development of its triple negative breast cancer treatment, CLX001. Triple negative breast cancer accounts for around 15% of breast cancers. It is usually more aggressive, harder to treat, and more likely to recur than many other cancers. CLX001 is a peptide in a nanoparticle formulation, developed for the treatment of…

Asahi Kasei Pharma has announced the new application period for their annual “Open Innovation” solicitation of proposals for drug discovery research. Through collaboration with universities, research institutes, and companies around the world, Asahi Kasei Pharma has been supporting innovation in drug discovery since 2018 and will fund up to $200,000 US per year for each selected proposal of the upcoming round in 2023. With “Global Specialty Pharma” highlighted as one of the 10 Growth Gears in our 2024 Medium-term Management Plan, endeavors like this for discovering new drugs for conditions…

  Apply to Win a Chance to Accelerate Your Innovation with Takeda UK!   Takeda UK, in partnership with The ADHD Foundation and Eastern AHSN (Academic Health Science Network), is launching a call for applications to our newest digital challenge to benefit patients who have Attention Deficit Hyperactivity Disorder (ADHD). What can Takeda offer? A dedicated point of contact at Takeda UK Finalists will receive a direct response about collaboration potential at the end of the Innovation Challenge Takeda’s resources & expertise Partnership with Takeda UK including…

Life science specialists – AMSBIO offer an extensive range of highly characterized, high purity exosomes for use as control standards in applications including marker assessment, immunocapture performance evaluation, exosome quantification, OMICS analysis, flow cytometry and electron microscopy. Exosomes or extracellular vesicles (EV) are small endosome derived lipid nanoparticles (50-300nm in diameter), actively secreted by exocytosis in most living cells. Exosomes have been shown to have pleiotropic physiological and pathological functions and play significant roles in diverse conditions…

ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women's health, has appointed Stella Panu as non-executive director. With over 20 years’ experience in corporate finance and investment management, Stella’s expertise will support the ValiRx Board and senior management team to unlock investment potential and accelerate and manage business growth for the company. In her role, she will also oversee ValiRx’s M&A activity, advising on corporate structure and governance, risk management, and shareholders’ rights. Stella was a founding partner of investment…

Now is not the time for complacency when it comes to cyber security, warns the National Cyber Security Centre (NCSC) . Cyber-security is part of Russia’s military doctrine, and whilst the UK has remained relatively unscathed to date, the impact of cyber activity against Ukrainian targets are being felt around the world. For example, Russia was behind a recent cyber-attack on a global communications company, which affected wind farms and internet users across Central Europe. As a result, the NCSC is encouraging all organisations to respond by maintaining a strengthened cyber-posture. The…

Located in the West of Scotland Science Park, this new facility will produce fresh leukopaks for cell and gene therapy research in the UK and Europe BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced the opening of its new blood donor center in Glasgow, Scotland. The company’s latest facility is located just outside Glasgow city center in the West of Scotland Science Park, which is home to more than 40 life science and technology businesses. The new donor center will be used primarily for producing LEUKOMAX® leukopaks…

  The Cambridge & South Cambs Committee of the Cambridgeshire Chambers of Commerce is running a series of events to tackle the ongoing challenges around recruitment for our Cambridge-based and regional firms. Starting this week, Thursday 20th October, the first event is being fronted by Nikki Scarr and Danielle Grant from Cambridge-based global life science company, Abcam. This in-person event, which is being held at the iconic Council Chamber in The Guildhall, Market Square, will focus on the need for companies to adapt to a new working environment and next-generation of employees,…